SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001013762-24-000886
Filing Date
2024-07-25
Accepted
2024-07-25 07:36:15
Documents
3
Period of Report
2024-07-25

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0210010-6k_purplebio.htm 6-K 14189
2 PRESS RELEASE ISSUED BY PURPLE BIOTECH LTD. ON JULY 25, 2024 ea021001001ex99-1_purplebio.htm EX-99.1 13545
3 GRAPHIC ex99-1_001.jpg GRAPHIC 4033
  Complete submission text file 0001013762-24-000886.txt   34708
Mailing Address 4 OPPENHEIMER STREET SCIENCE PARK REHOVOT L3 7670104
Business Address 4 OPPENHEIMER STREET SCIENCE PARK REHOVOT L3 7670104 97239333121
PURPLE BIOTECH LTD. (Filer) CIK: 0001614744 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37643 | Film No.: 241139824
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)